Back

ESMO Plenary Dec 2021 - ESMO Virtual Plenaries: December 2021

Dec 16 - Dec 17, 2021 | LuganoSwitzerland

LARVOL is not affiliated with ESMO Virtual Plenaries: December 2021 and all trademarks, logos, and brand names are property of their respective owners

Top Products
Condition
Product
MOA
Trial Name/ID

Showing 1 abstracts linked to Trials

Trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab as first line treatment for patients with metastatic colorectal cancer (mCRC) ineligible for intensive therapy: The phase III randomized SOLSTICE study